Evidence map›Paper›PMID 34038082›Full record

ArticleACS applied materials & interfaces2021

Metal-Free Antibacterial Additives Based on Graphene Materials and Salicylic Acid: From the Bench to Fabric Applications.

Giacomo Biagiotti, Annalisa Salvatore, Gianluca Toniolo, Lucrezia Caselli, Maura Di Vito, Margherita Cacaci, Luca Contiero, Tommaso Gori, Michele Maggini, Maurizio Sanguinetti and 4 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Viniferin-Rich Phytocomplex fromMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Curcumin-Functionalized Graphene Oxide Strongly PreventsPharmaceuticals (Basel, Switzerland) · 2023
    Article
  5. Advances in Biologically Applicable Graphene-Based 2D Nanomaterials.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giacomo BiagiottiDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.
Annalisa SalvatoreCSGI (Italian Center for Colloid and Surface Science, Via della Lastruccia 3, 50019 Sesto Fiorentino, Firenze, Italy.
Gianluca TonioloDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.
Lucrezia CaselliDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.
Maura Di VitoDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Margherita CacaciDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Luca ContieroCromology Italia S.p.A., Via IV Novembre, 4, 55016 Z.I. Porcari, Lucca, Italy.
Tommaso GoriBeste S.p.A., Via Primo Levi, 6, 59022 Colle Cantagallo, Prato, Italy.
Michele MagginiDipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131 Padova, Italy.ORCID https://orcid.org/0000-0001-8149-5903
Maurizio SanguinettiDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Debora BertiDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID https://orcid.org/0000-0001-8967-560X
Francesca BugliDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Barbara RichichiDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID https://orcid.org/0000-0001-7093-9513
Stefano CicchiDepartment of Chemistry "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID https://orcid.org/0000-0002-4913-6414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The custom functionalization of a graphene surface allows access to engineered nanomaterials with improved colloidal stability and tailored specific properties, which are available to be employed in a wide range of applications ranging from materials to life science. The high surface area and their intrinsic physical and biological properties make reduced graphene oxide and graphene oxide unique materials for the custom functionalization with bioactive molecules by exploiting different surface chemistries. In this work, preparation (on the gram scale) of reduced graphene oxide and graphene oxide derivatives functionalized with the well-known antibacterial agent salicylic acid is reported. The salicylic acid functionalities offered a stable colloidal dispersion and, in addition, homogeneous absorption on a sample of textile manufacture (i.e., cotton fabrics), as shown by a Raman spectroscopy study, thus providing nanoengineered materials with significant antibacterial activity toward different strains of microorganisms. Surprisingly, graphene surface functionalization also ensured resistance to detergent washing treatments as verified on a model system using the quartz crystal microbalance technique. Therefore, our findings paved the way for the development of antibacterial additives for cotton fabrics in the absence of metal components, thus limiting undesirable side effects.

Indexed as

Anti-Bacterial AgentsBacteriaGraphiteNanostructuresSalicylic AcidTextilesAnti-Bacterial Agentsgraphene oxideGraphiteSalicylic Acidantibacterial activityball millingcotton fabricsgraphenegraphene oxidequartz crystal microbalanceRamansalicylic acid

Identifiers

PMID34038082
PMCPMC8289172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.